Lu Li

Identification of potential plasma markers for hepatitis B virus‐related chronic hepatitis and liver fibrosis/cirrhosis

Y. Nan, Suxian Zhao, C. Dong, 2022, Journal of medical virology.

Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology

Yang Wang, Yang Wang, Y. Nan, 2022, Journal of hepatocellular carcinoma.

Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B

J. Shang, Y. Nan, Xiaoxiao Zhang, 2022, Journal of clinical and translational hepatology.

Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study

Y. Nan, Lingdi Liu, T. Han, 2022, Canadian journal of gastroenterology & hepatology.

LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p

Y. Nan, Lu Li, Shiming Dong, 2023, Journal of hepatocellular carcinoma.

Mitofusin-2 gene polymorphisms and metabolic dysfunction associated fatty liver disease: a case-control study in a Chinese population

Y. Nan, H. Du, Lu Li, 2023, Journal of International Medical Research.

Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis

Y. Nan, Suxian Zhao, Rong Ai, 2023, Lipids in Health and Disease.

Association of Helicobacter pylori Infection with Depression and Anxiety: A Systematic Review and Meta‐Analysis

Zeyu Wang, Lu Li, Ying Zhao, 2024, International Journal of Clinical Practice.